サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631223

化粧品用ペプチド製造の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Cosmetic Peptide Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 224 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
化粧品用ペプチド製造の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月03日
発行: Fairfield Market Research
ページ情報: 英文 224 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

化粧品用ペプチド製造市場は、技術の進歩、アンチエイジング・ソリューションに対する消費者の需要の増加、持続可能な美容製品への注目の高まりに後押しされ、かつてない成長を遂げています。ペプチドは、老化、色素沈着、保湿などの特定の肌悩みをターゲットにする能力で知られ、現代のスキンケア製剤に不可欠な成分となっています。世界の化粧品用ペプチド製造の市場規模は、5.6%のCAGRで拡大し、2025年には2億4,700万米ドル、2032年には3億6,177万米ドルに達すると予測されています。この成長の原動力は、ペプチドの合成に革命をもたらし、消費者のニーズに合わせた正確な処方を可能にしたバイオテクノロジーの飛躍的進歩です。

複数の肌悩みに対応できるペプチドの汎用性により、ペプチドは化粧品製剤に不可欠なものと位置づけられています。化粧品用ペプチド製造市場は、進化する消費者の嗜好と技術の進歩に合わせて大きく成長する態勢を整えています。ペプチド合成における技術革新は、パーソナライズされた持続可能なスキンケアの台頭と相まって、この市場を美容・パーソナルケア業界における変革的な力として位置づけています。主要企業が技術革新を推進し、地域市場が多様な機会を提供することで、この業界は現代のスキンケアソリューションを再定義しようとしています。

メーカーは、再生可能資源由来のペプチドや生分解性素材を利用したペプチドを開発することで、環境意識の高い消費者に対応し、クリーン・ビューティーのトレンドを活用することができます。南アジアや太平洋地域などの急速な都市化と可処分所得の増加は、市場拡大の好機となります。AIを活用したスキンケア分析と製品のカスタマイズのためのデジタルプラットフォームの活用により、消費者のエンゲージメントとロイヤルティを高めることができます。

当レポートでは、世界の化粧品用ペプチド製造市場について調査し、市場の概要とともに、製品別、用途別、最終製品別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の化粧品用ペプチド製造市場の見通し、2019年～2032年

  • 世界の化粧品用ペプチド製造市場の見通し、製品別、金額（100万米ドル）、2019年～2032年
  • 世界の化粧品用ペプチド製造市場の見通し、用途別、金額（100万米ドル）、2019年～2032年
  • 世界の化粧品用ペプチド製造市場の見通し、最終製品別、金額（100万米ドル）、2019年～2032年
  • 世界の化粧品用ペプチド製造市場の見通し、エンドユーザー別、金額（100万米ドル）、2019年～2032年
  • 世界の化粧品用ペプチド製造市場の見通し、地域別、金額（100万米ドル）、2019年～2032年

第4章 北米の化粧品用ペプチド製造市場の見通し、2019年～2032年

第5章 欧州の化粧品用ペプチド製造市場の見通し、2019年～2032年

第6章 アジア太平洋の化粧品用ペプチド製造市場の見通し、2019年～2032年

第7章 ラテンアメリカの化粧品用ペプチド製造市場の見通し、2019年～2032年

第8章 中東・アフリカの化粧品用ペプチド製造市場の見通し、2019年～2032年

第9章 競合情勢

  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Croda International plc
    • Merck KGaA
    • USV Private Limited
    • BASF SE
    • CEM Corporation
    • Bachem Holding AG
    • CPC Scientific Inc.
    • Creative Peptides
    • Bio-Synthesis Inc.
    • CSBio China

第10章 付録

目次

The cosmetic peptide manufacturing market is experiencing unprecedented growth, fueled by technological advancements, increasing consumer demand for anti-aging solutions, and a rising focus on sustainable beauty products. Peptides, known for their ability to target specific skin concerns such as aging, pigmentation, and hydration, have become essential components in modern skincare formulations. The global cosmetic peptide manufacturing market is projected to grow at a CAGR of 5.6%, reaching a value of USD 247 million by 2025 and USD 361.77 million by 2032. This growth is driven by breakthroughs in biotechnology that have revolutionized the synthesis of peptides, enabling precise formulations tailored to consumer needs

Market Insights

The global cosmetic peptide manufacturing market is projected to grow at a CAGR of 5.6%, reaching a value of USD 247 million by 2025 and USD 361.77 million by 2032. This growth is driven by breakthroughs in biotechnology that have revolutionized the synthesis of peptides, enabling precise formulations tailored to consumer needs. Peptides' versatility in addressing multiple skin concerns has positioned them as indispensable in cosmetic formulations. The cosmetic peptide manufacturing market is poised for substantial growth as it aligns with evolving consumer preferences and technological advancements. Innovations in peptide synthesis, coupled with the rise of personalized and sustainable skincare, position this market as a transformative force in the beauty and personal care industry. With key players driving innovation and regional markets presenting diverse opportunities, the industry is set to redefine modern skincare solutions.

Drivers of Growth

  • 1. Advances in Biotechnology: Innovative techniques such as solid-phase peptide synthesis and recombinant DNA technology have enhanced the efficiency and specificity of peptide production, enabling the development of cutting-edge skincare solutions.
  • 2. Rising Demand for Anti-Aging Products: Consumers increasingly seek products that address visible signs of aging, such as wrinkles and fine lines. Peptides, known for stimulating collagen production and promoting skin elasticity, are at the forefront of this trend.
  • 3. Sustainability and Clean Beauty Movement: The growing emphasis on sustainable and eco-friendly beauty solutions has prompted manufacturers to develop green peptide formulations, aligning with consumer preferences for environmentally conscious products.
  • 4. Personalized Skincare: Advances in technology have enabled personalized skincare solutions, allowing manufacturers to create bespoke peptide formulations tailored to individual needs, further driving market growth.

Business Opportunities

  • 1. Sustainable Peptide Formulations: Manufacturers can capitalize on the clean beauty trend by developing peptides derived from renewable resources or utilizing biodegradable materials, catering to environmentally conscious consumers.
  • 2. Expansion into Emerging Markets: Rapid urbanization and increasing disposable income in regions such as South Asia and the Pacific present lucrative opportunities for market expansion.
  • 3. Integration of AI and Digital Technologies: Leveraging AI-driven skincare analysis and digital platforms for product customization can enhance consumer engagement and loyalty.

Regional Analysis

  • 1. Europe: The Market Leader Europe dominates the cosmetic peptide manufacturing market due to its advanced industry infrastructure, stringent regulatory standards, and strong R&D capabilities. The region's focus on premium beauty products further bolsters its leadership position.
  • 2. South Asia & Pacific: A Rapidly Growing Market With a thriving beauty and personal care industry, the South Asia & Pacific region is witnessing accelerated growth. Factors such as an aging population, rising skincare awareness, and advancements in healthcare infrastructure contribute to this region's market expansion.

Key Players Prominent companies driving innovation and market growth include:

  • Croda International Plc
  • Ashland
  • DSM (Koninklijke DSM NV)
  • Bachem
  • Genscript Biotech Corp
  • BASF SE
  • Geltor
  • The Lubrizol Corporation
  • Symrise
  • Bio Basic Inc.
  • Regeron Inc.

Market Segmentation The cosmetic peptide manufacturing market is segmented based on product type, application, end-user, and region.

1. By Product Type:

    Signal Peptides Neurotransmitter Inhibitors Carrier Peptides Enzyme Inhibitor Peptides Structural Peptides Synthetic Antimicrobial Peptides (AMPs) Others

2. By Application:

    Anti-Aging Eye Care Anti-Pigmentation Hair Growth

3. By End User:

    Cosmetic Manufacturers Cosmetic Contract Manufacturers Biopharmaceutical Industries (Personal Care)

4. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cosmetic Peptide Manufacturing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Porter's Five Forces Analysis
  • 2.4. COVID-19 Impact Analysis
    • 2.4.1. Supply
    • 2.4.2. Demand
  • 2.5. Impact of Ukraine-Russia Conflict
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Global Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 3.1. Global Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Neurotransmitter Inhibitors
      • 3.1.1.2. Enzyme Inhibitor Peptides
      • 3.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 3.1.1.4. Signal Peptides
      • 3.1.1.5. Carrier Peptides
      • 3.1.1.6. Others
  • 3.2. Global Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Whitening
      • 3.2.1.2. Anti-Aging
      • 3.2.1.3. Hair/Eyecare/Eyelash Care
      • 3.2.1.4. Slimming & Breast Enhancement
      • 3.2.1.5. Others
  • 3.3. Global Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Skin Care
        • 3.3.1.1.1. Sunscreen Lotion
        • 3.3.1.1.2. Serum
        • 3.3.1.1.3. Creams and Moisturizers
      • 3.3.1.2. Eye Care
        • 3.3.1.2.1. Serum
        • 3.3.1.2.2. Cream
      • 3.3.1.3. Hair Care
        • 3.3.1.3.1. Serum
        • 3.3.1.3.2. Cream
      • 3.3.1.4. Others
  • 3.4. Global Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. Cosmetic Manufacturers
      • 3.4.1.2. Cosmetic Contract Manufacturers
      • 3.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 3.5. Global Cosmetic Peptide Manufacturing Market Outlook, by Region, Value (US$ Mn), 2019 - 2032
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 4.1. North America Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Neurotransmitter Inhibitors
      • 4.1.1.2. Enzyme Inhibitor Peptides
      • 4.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 4.1.1.4. Signal Peptides
      • 4.1.1.5. Carrier Peptides
      • 4.1.1.6. Others
  • 4.2. North America Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Whitening
      • 4.2.1.2. Anti-Aging
      • 4.2.1.3. Hair/Eyecare/Eyelash Care
      • 4.2.1.4. Slimming & Breast Enhancement
      • 4.2.1.5. Others
  • 4.3. North America Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Skin Care
        • 4.3.1.1.1. Sunscreen Lotion
        • 4.3.1.1.2. Serum
        • 4.3.1.1.3. Creams and Moisturizers
      • 4.3.1.2. Eye Care
        • 4.3.1.2.1. Serum
        • 4.3.1.2.2. Cream
      • 4.3.1.3. Hair Care
        • 4.3.1.3.1. Serum
        • 4.3.1.3.2. Cream
      • 4.3.1.4. Others
  • 4.4. North America Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Cosmetic Manufacturers
      • 4.4.1.2. Cosmetic Contract Manufacturers
      • 4.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 4.5. North America Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.2. U.S. Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 4.5.1.3. U.S. Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.4. U.S. Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 4.5.1.5. Canada Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.6. Canada Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 4.5.1.7. Canada Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 4.5.1.8. Canada Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 5.1. Europe Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Neurotransmitter Inhibitors
      • 5.1.1.2. Enzyme Inhibitor Peptides
      • 5.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 5.1.1.4. Signal Peptides
      • 5.1.1.5. Carrier Peptides
      • 5.1.1.6. Others
  • 5.2. Europe Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Whitening
      • 5.2.1.2. Anti-Aging
      • 5.2.1.3. Hair/Eyecare/Eyelash Care
      • 5.2.1.4. Slimming & Breast Enhancement
      • 5.2.1.5. Others
  • 5.3. Europe Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Skin Care
        • 5.3.1.1.1. Sunscreen Lotion
        • 5.3.1.1.2. Serum
        • 5.3.1.1.3. Creams and Moisturizers
      • 5.3.1.2. Eye Care
        • 5.3.1.2.1. Serum
        • 5.3.1.2.2. Cream
      • 5.3.1.3. Hair Care
        • 5.3.1.3.1. Serum
        • 5.3.1.3.2. Cream
      • 5.3.1.4. Others
  • 5.4. Europe Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Cosmetic Manufacturers
      • 5.4.1.2. Cosmetic Contract Manufacturers
      • 5.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 5.5. Europe Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.2. Germany Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.3. Germany Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.4. Germany Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.5. U.K. Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.6. U.K. Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.7. U.K. Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.8. U.K. Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.9. France Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.10. France Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.11. France Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.12. France Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.13. Italy Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.14. Italy Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.15. Italy Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.16. Italy Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.17. Turkey Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.18. Turkey Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.19. Turkey Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.20. Turkey Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.21. Russia Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.22. Russia Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.23. Russia Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.24. Russia Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 5.5.1.25. Rest of Europe Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.26. Rest of Europe Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 5.5.1.27. Rest of Europe Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 5.5.1.28. Rest of Europe Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Neurotransmitter Inhibitors
      • 6.1.1.2. Enzyme Inhibitor Peptides
      • 6.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 6.1.1.4. Signal Peptides
      • 6.1.1.5. Carrier Peptides
      • 6.1.1.6. Others
  • 6.2. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Whitening
      • 6.2.1.2. Anti-Aging
      • 6.2.1.3. Hair/Eyecare/Eyelash Care
      • 6.2.1.4. Slimming & Breast Enhancement
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Skin Care
        • 6.3.1.1.1. Sunscreen Lotion
        • 6.3.1.1.2. Serum
        • 6.3.1.1.3. Creams and Moisturizers
      • 6.3.1.2. Eye Care
        • 6.3.1.2.1. Serum
        • 6.3.1.2.2. Cream
      • 6.3.1.3. Hair Care
        • 6.3.1.3.1. Serum
        • 6.3.1.3.2. Cream
      • 6.3.1.4. Others
  • 6.4. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Cosmetic Manufacturers
      • 6.4.1.2. Cosmetic Contract Manufacturers
      • 6.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 6.5. Asia Pacific Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.2. China Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.3. China Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.4. China Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.5. Japan Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.6. Japan Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.7. Japan Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.8. Japan Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.9. South Korea Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.10. South Korea Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.11. South Korea Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.12. South Korea Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.13. India Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.14. India Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.15. India Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.16. India Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.17. Southeast Asia Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.18. Southeast Asia Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.19. Southeast Asia Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.20. Southeast Asia Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 6.5.1.21. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.22. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 6.5.1.23. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 6.5.1.24. Rest of Asia Pacific Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 7.1. Latin America Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Neurotransmitter Inhibitors
      • 7.1.1.2. Enzyme Inhibitor Peptides
      • 7.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 7.1.1.4. Signal Peptides
      • 7.1.1.5. Carrier Peptides
      • 7.1.1.6. Others
  • 7.2. Latin America Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Whitening
      • 7.2.1.2. Anti-Aging
      • 7.2.1.3. Hair/Eyecare/Eyelash Care
      • 7.2.1.4. Slimming & Breast Enhancement
      • 7.2.1.5. Others
  • 7.3. Latin America Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Skin Care
        • 7.3.1.1.1. Sunscreen Lotion
        • 7.3.1.1.2. Serum
        • 7.3.1.1.3. Creams and Moisturizers
      • 7.3.1.2. Eye Care
        • 7.3.1.2.1. Serum
        • 7.3.1.2.2. Cream
      • 7.3.1.3. Hair Care
        • 7.3.1.3.1. Serum
        • 7.3.1.3.2. Cream
      • 7.3.1.4. Others
  • 7.4. Latin America Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Cosmetic Manufacturers
      • 7.4.1.2. Cosmetic Contract Manufacturers
      • 7.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 7.5. Latin America Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.2. Brazil Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.3. Brazil Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.4. Brazil Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.5. Mexico Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.6. Mexico Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.7. Mexico Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.8. Mexico Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.9. Argentina Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.10. Argentina Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.11. Argentina Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.12. Argentina Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 7.5.1.13. Rest of Latin America Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.14. Rest of Latin America Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 7.5.1.15. Rest of Latin America Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 7.5.1.16. Rest of Latin America Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By Product, Value (US$ Mn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Neurotransmitter Inhibitors
      • 8.1.1.2. Enzyme Inhibitor Peptides
      • 8.1.1.3. Synthetic Antimicrobial Peptides (AMPs)
      • 8.1.1.4. Signal Peptides
      • 8.1.1.5. Carrier Peptides
      • 8.1.1.6. Others
  • 8.2. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By Application, Value (US$ Mn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Whitening
      • 8.2.1.2. Anti-Aging
      • 8.2.1.3. Hair/Eyecare/Eyelash Care
      • 8.2.1.4. Slimming & Breast Enhancement
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By End Product, Value (US$ Mn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Skin Care
        • 8.3.1.1.1. Sunscreen Lotion
        • 8.3.1.1.2. Serum
        • 8.3.1.1.3. Creams and Moisturizers
      • 8.3.1.2. Eye Care
        • 8.3.1.2.1. Serum
        • 8.3.1.2.2. Cream
      • 8.3.1.3. Hair Care
        • 8.3.1.3.1. Serum
        • 8.3.1.3.2. Cream
      • 8.3.1.4. Others
  • 8.4. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, By End User, Value (US$ Mn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Cosmetic Manufacturers
      • 8.4.1.2. Cosmetic Contract Manufacturers
      • 8.4.1.3. Biopharmaceutical Industries (Personal Care)
  • 8.5. Middle East & Africa Cosmetic Peptide Manufacturing Market Outlook, by Country, Value (US$ Mn), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.2. GCC Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.3. GCC Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.4. GCC Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.5. South Africa Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.6. South Africa Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.7. South Africa Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.8. South Africa Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.9. Egypt Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.10. Egypt Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.11. Egypt Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.12. Egypt Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.13. Nigeria Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.14. Nigeria Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.15. Nigeria Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.16. Nigeria Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
      • 8.5.1.17. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.18. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By Application, Value (US$ Mn), 2019 - 2032
      • 8.5.1.19. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By End Product, Value (US$ Mn), 2019 - 2032
      • 8.5.1.20. Rest of Middle East & Africa Cosmetic Peptide Manufacturing Market By End User, Value (US$ Mn), 2019 - 2032
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2024
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Croda International plc
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Merck KGaA
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. USV Private Limited
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. BASF SE
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. CEM Corporation
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Bachem Holding AG
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. CPC Scientific Inc.
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Creative Peptides
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Bio-Synthesis Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. CSBio China
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Product Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations